Trial Profile
Efficacy and safety of lenalidomide and dexamethasone in Japanese subjects with refractory/relapsed multiple myeloma.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Sep 2015
Price :
$35
*
At a glance
- Drugs Dexamethasone (Primary) ; Lenalidomide (Primary)
- Indications Multiple myeloma
- Focus Therapeutic Use
- 11 Sep 2015 New trial record